Hotgen
688068109.336.03% ( +6.22 )
Hotgen (688068)
Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagno...
- Open
- 105.17
- High
- 110.70
- Low
- 103.15
- Prev. Close
- 103.11
- Volume
- 17.09K
- Turnover
- 184.75M
- Avg Price
- 108.09
- Bid/Ask Ratio
- --
- Amplitude
- 7.32%
- 52wk High
- 262.22
- Volume Ratio
- 1.19
- Turnover Ratio
- 1.84%
News
- 36Kr · Apr 2 at 06:04 AM
Hotgen: Has repurchased 904,100 shares, using a total of 150 million yuan
- 36Kr · Jan 5 at 01:07 AM
The three major A-share indices collectively closed higher, with the Shanghai Composite Index returning to 4,000 points
- Zhitong · Nov 3, 2025 at 02:20 AM
Hotgen's invested company has obtained domestic Class III medical device registration certificate
- Zhitong · Oct 23, 2025 at 04:36 AM
Hotgen released its performance for the first three quarters, with a net loss attributable to the parent company of 109 million yuan
- Zhitong · Oct 22, 2025 at 03:11 AM
Hotgen's invested company SGC001's innovative drug Phase Ib clinical trial has obtained positive preliminary results
- Zhitong · Sep 10, 2025 at 09:20 PM
The concept of innovative drugs has rebounded, with Chimin gaining 6 limit-ups in 12 days, Staidson BioPharm rising over 7%, Hotgen increasing over 5%, and stocks like Medicilon, Cosunter, and BrightGene also seeing gains
